Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry.
Suwa M, Morii I, Kino M, Matsui Y, Yoshinaga M, Takahashi H, Takagi M, Yoshida A, Ichikawa M, Nakajima O, Tanimura M, Shimoyama H, Saitoh H, Sasaki I, Suzuki T, Uemae S. Suwa M, et al. Among authors: shimoyama h. Pharmaceuticals (Basel). 2024 Oct 25;17(11):1431. doi: 10.3390/ph17111431. Pharmaceuticals (Basel). 2024. PMID: 39598343 Free PMC article.
The first case of primary malignant melanoma of the esophagus to achieve pathologic complete response after preoperative ipilimumab + nivolumab followed by resection.
Shibayama R, Fujisawa K, Ogawa Y, Shimoyama H, Ohkura Y, Honda A, Haruta S, Udagawa H, Ueno M, Takazawa Y. Shibayama R, et al. Among authors: shimoyama h. Clin J Gastroenterol. 2024 Oct 31. doi: 10.1007/s12328-024-02050-6. Online ahead of print. Clin J Gastroenterol. 2024. PMID: 39477873
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Kikuchi E, Hayakawa N, Nakayama M, Uno M, Nakatsu H, Kitagawa C, Miyake H, Yamada T, Fujita K, Shimoyama H, Nishihara K, Kobayashi M, Nakamura M, Fujimoto K, Sano T, Nishiyama N, Ito T, Kajita M, Kobayashi T, Kitamura H. Kikuchi E, et al. Among authors: shimoyama h. Int J Urol. 2024 Aug;31(8):859-867. doi: 10.1111/iju.15473. Epub 2024 May 9. Int J Urol. 2024. PMID: 38722221 Free PMC article.
140 results